Pharmacokinetics
Acronym for: PK/PD
Also known as: PK/PD, ADMET, Drug Metabolism
Study of how the body absorbs, distributes, metabolizes, and excretes drugs — now predicted with high accuracy by AI models.
Pharmacokinetics (PK/PD) is a critical concept in digital biology. Study of how the body absorbs, distributes, metabolizes, and excretes drugs — now predicted with high accuracy by AI models. Understanding pharmacokinetics is essential for pk/pd modeling predicts drug behavior in the body, critical for dosing, safety, and efficacy. ai-powered admet (absorption, distribution, metabolism, excretion, toxicity) prediction identifies problematic compounds early, reducing late-stage clinical failures. machine learning models trained on millions of experimental measurements predict metabolic stability, bioavailability, and toxicity endpoints with increasing accuracy.. This guide explains how pharmacokinetics works in practice, provides real-world examples, and connects to related digital biology concepts.
Definition
Technically, Pharmacokinetics (PK/PD) means study of how the body absorbs, distributes, metabolizes, and excretes drugs — now predicted with high accuracy by ai models. PK/PD modeling predicts drug behavior in the body, critical for dosing, safety, and efficacy. AI-powered ADMET (absorption, distribution, metabolism, excretion, toxicity) prediction identifies problematic compounds early, reducing late-stage clinical failures. Machine learning models trained on millions of experimental measurements predict metabolic stability, bioavailability, and toxicity endpoints with increasing accuracy. The concept applies to Simulations Plus using AI models to predict ADMET properties for drug candidates. For example, schrödinger deploying physics-based ai for pk prediction in lead optimization. Understanding pharmacokinetics helps industry professionals evaluate AI platforms and deployment strategies.
Applications
Real-world applications of Pharmacokinetics include: Simulations Plus using AI models to predict ADMET properties for drug candidates; Schrödinger deploying physics-based AI for PK prediction in lead optimization; Certara using AI-enhanced PK/PD modeling for clinical trial dose optimization. enterprises implementing AI solutions encounter pharmacokinetics when pk/pd modeling predicts drug behavior in the body, critical for dosing, safety, and efficacy. ai-powered admet (absorption, distribution, metabolism, excretion, toxicity) prediction identifies problematic compounds early, reducing late-stage clinical failures. machine learning models trained on millions of experimental measurements predict metabolic stability, bioavailability, and toxicity endpoints with increasing accuracy.. The concept enables simulations plus using ai models to predict admet properties for drug candidates across operations.
Related Concepts
Pharmacokinetics is closely related to: AI Drug Discovery, Computational Chemistry, Clinical Trials. Alternative terms include: PK/PD, ADMET, Drug Metabolism. Industry professionals evaluating AI solutions should understand how pharmacokinetics interacts with AI Drug Discovery. This knowledge informs better vendor selection and deployment strategies.
Context
PK/PD modeling predicts drug behavior in the body, critical for dosing, safety, and efficacy. AI-powered ADMET (absorption, distribution, metabolism, excretion, toxicity) prediction identifies problematic compounds early, reducing late-stage clinical failures. Machine learning models trained on millions of experimental measurements predict metabolic stability, bioavailability, and toxicity endpoints with increasing accuracy.
Examples
- 1Simulations Plus using AI models to predict ADMET properties for drug candidates
- 2Schrödinger deploying physics-based AI for PK prediction in lead optimization
- 3Certara using AI-enhanced PK/PD modeling for clinical trial dose optimization